Medicine and Dentistry
Patient
100%
Programmed Cell Death
64%
Ligand
51%
Non Small Cell Lung Cancer
44%
Lung Adenocarcinoma
40%
Neoplasm
39%
Programmed Death 1 Ligand 1
36%
Lung Cancer
28%
Inpatient
26%
Overall Survival
24%
Surgery
20%
Association
19%
Epidermal Growth Factor Receptor
18%
Indoleamine 2,3 Dioxygenase
17%
Immune Checkpoint Inhibitor
15%
Predictor
13%
Disease Free Survival
13%
Prognostic Factor
13%
Tumor Infiltrating Lymphocyte
12%
Adenocarcinoma
12%
Cells
12%
Squamous Cell Lung Carcinoma
12%
Survival
12%
Tumor Cell
11%
Therapeutic Procedure
11%
Nutritional Status
10%
Ground Glass Opacity
10%
Immunotherapy
10%
Marker
9%
Programmed Cell Death
9%
Lesion
9%
Pneumonectomy
8%
Serum
8%
Immunohistochemistry
8%
Protein
8%
Multivariate Analysis
8%
Combination Therapy
8%
Malignant Neoplasm
8%
Prognosis
8%
Small Cell Lung Cancer
7%
Computer Assisted Tomography
7%
Smoking
7%
Clinical Significance
7%
Analysis
7%
Recurrent Disease
6%
Lymphocyte
6%
Probiotic Agent
6%
Interleukin-38
6%
Lung Metastasis
6%
Hazard Ratio
6%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
31%
Ligand
30%
Programmed Death 1 Ligand 1
15%
Programmed Cell Death
12%
Immune Checkpoint Inhibitor
10%
Lung Cancer
10%
Overall Survival
9%
Indoleamine 2,3 Dioxygenase
9%
Survival
9%
Immunotherapy
8%
Chemotherapy
8%
Albumin
8%
Neoplasm
8%
Probiotic Agent
6%
Progression Free Survival
5%
Prospective Study
5%
Prognosis
5%
Biochemistry, Genetics and Molecular Biology
Apoptosis
17%
Transcription Factor EZH2
13%
Association
8%
Overall Survival
8%
Mutation
7%
Survival
7%
Programmed Cell Death 1
7%
Epidermal Growth Factor Receptor
6%
Antibody
5%